Skip to NavigationSkip to content

Takeda opens R&D facility in San Diego, California

Published on 02/05/19 at 10:30am

Japanese-firm Takeda pharmaceuticals has opened a new research facility in San Diego, California. The 165,000ft2 research centre will employ 250 staff.

The new facility will be focused on drug discovery in the areas of neuroscience and gastroenterology (GI).

The centre houses research platform groups across structural and computational biology, early target discovery and biologics for the advancement of potential molecules.

Takeda hopes the facility will supplement its R&D centres in Cambridge, Massachusetts and Shonan, Japan.

Takeda Pharmaceutical Research head Steve Hitchcock commented: “Our San Diego research centre demonstrates an ideal balance between highly specialised internal research competencies and dedication to external partnerships both within the local community and on a global scale.”  

“By consulting with and leveraging our relationships with academic and industry partners and patient groups, we are able to operate nimbly and efficiently to advance early discovery research that could potentially translate into transformative, life-changing therapies for patients in need, complementing our efforts in our other global research centres in Cambridge and Shonan.”

Louis Goss

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches